Concepedia

Jingyi Xiang

JX

Statistics

Publications

11

Citations

1.5K

H-Index

11

Active since

1999

Affiliations

Eureka Therapeutics (United States)(Current)

Cornell University

Memorial Sloan Kettering Cancer Center

Stony Brook University

State University of New York

Jingyi Xiang is an author at Eureka Therapeutics (United States) specializing in oncology, immunology, and cancer immunotherapy.

Publications per year

1999–2025

11

Publications

11

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al. · Nature Biotechnology · 2018 · 823 citations

Medicine, Immunology, Oncology +16

Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer

Hong Liu, Yiyang Xu, Jingyi Xiang et al. · Clinical Cancer Research · 2016 · 230 citations

Life Sciences, Immunology, Oncology +17

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1

Tao Dao, Dmitry Pankov, Andrew Scott et al. · Nature Biotechnology · 2015 · 161 citations · Full text

Life Sciences, Immunology, Oncology +14

Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics

Niloufar Ataie, Jingyi Xiang, Neal Cheng et al. · Journal of Molecular Biology · 2015 · 69 citations · Full text

Pharmacy, Immunology, Molecular Biology +14

Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein

Nicholas Veomett, Tao Dao, Hong Liu et al. · Clinical Cancer Research · 2014 · 50 citations · Full text

Pharmacy, Immunology, Oncology +17

1–5 of 11